Ardelyx (ARDX) Cash from Financing Activities (2014 - 2026)

Ardelyx (ARDX) reported Cash from Financing Activities of $5.4 million for Q1 2026, up 267.21% on a YoY basis from $1.5 million in Q1 2025, and up 877.02% quarter-over-quarter from $557000.0 in Q4 2025.

Ardelyx (ARDX) Cash from Financing Activities (2014 - 2026) Analysis & Trends

Ardelyx has reported Cash from Financing Activities for 13 years, with the latest figure at $5.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities rose 267.21% year-over-year to $5.4 million; the trailing twelve-month figure through Mar 2026 stood at $58.5 million (up 6.11% YoY), and the FY2025 full-year result was $54.5 million, down 48.86% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at $5.4 million, up from $557000.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $57.9 million in Q3 2023, with the low at -$63000.0 in Q1 2022.
  • Historically, Cash from Financing Activities has averaged $22.8 million across 5 years, with a median of $18.8 million in 2022.
  • Annual changes were most pronounced in 2022 — Cash from Financing Activities tumbled 100.18% — and 2023, when it jumped 80923.81%.
  • Ardelyx's Cash from Financing Activities stood at $18.8 million in 2022, then surged by 38.33% to $26.0 million in 2023, then soared by 89.75% to $49.3 million in 2024, then slumped by 98.87% to $557000.0 in 2025, then jumped by 877.02% to $5.4 million in 2026.
  • The last three Cash from Financing Activities figures came in at $5.4 million (Q1 2026), $557000.0 (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Ardelyx 1.49 Bn 1.25 Bn 89.66 Mn 5.44 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.44 Mn
Mar 31, 2026 5.44 Mn
Dec 31, 2025 557,000.00
Dec 31, 2025 557,000.00
Sep 30, 2025 2.81 Mn
Sep 30, 2025 2.81 Mn
Jun 30, 2025 49.66 Mn
Jun 30, 2025 49.66 Mn
Mar 31, 2025 1.48 Mn
Mar 31, 2025 1.48 Mn
Dec 31, 2024 49.31 Mn
Dec 31, 2024 49.31 Mn
Sep 30, 2024 2.70 Mn
Sep 30, 2024 2.70 Mn
Jun 30, 2024 1.61 Mn
Jun 30, 2024 1.61 Mn
Mar 31, 2024 52.97 Mn
Mar 31, 2024 52.97 Mn
Dec 31, 2023 25.99 Mn
Dec 31, 2023 25.99 Mn